88 related articles for article (PubMed ID: 1642473)
1. An abnormality of plasma amyloid protein precursor in Alzheimer's disease.
Bush AI; Whyte S; Thomas LD; Williamson TG; Van Tiggelen CJ; Currie J; Small DH; Moir RD; Li QX; Rumble B
Ann Neurol; 1992 Jul; 32(1):57-65. PubMed ID: 1642473
[TBL] [Abstract][Full Text] [Related]
2. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
[TBL] [Abstract][Full Text] [Related]
3. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
5. The amyloid peptide precursor in Alzheimer's disease.
Octave JN
Acta Neurol Belg; 1995 Dec; 95(4):197-209. PubMed ID: 8553793
[TBL] [Abstract][Full Text] [Related]
6. Differential distribution of amyloid protein precursor immunoreactivity in the rat brain studied by using five different antibodies.
Beeson JG; Shelton ER; Chan HW; Gage FH
J Comp Neurol; 1994 Apr; 342(1):78-96. PubMed ID: 8207129
[TBL] [Abstract][Full Text] [Related]
7. [Expression of amyloid beta-protein gene in Alzheimer's disease].
Tanaka S; Nakamura S; Ueda K
Rinsho Byori; 1990 May; 38(5):489-93. PubMed ID: 2116540
[TBL] [Abstract][Full Text] [Related]
8. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH
J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314
[TBL] [Abstract][Full Text] [Related]
9. Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms.
Borroni B; Colciaghi F; Corsini P; Akkawi N; Rozzini L; Del Zotto E; Talarico G; Cattabeni F; Lenzi GL; Di Luca M; Padovani A
Neurol Sci; 2002 Dec; 23(5):207-10. PubMed ID: 12522675
[TBL] [Abstract][Full Text] [Related]
10. Increased release of an amyloidogenic C-terminal Alzheimer amyloid precursor protein fragment from stressed PC-12 cells.
Baskin F; Rosenberg RN; Greenberg BD
J Neurosci Res; 1991 May; 29(1):127-32. PubMed ID: 1909380
[TBL] [Abstract][Full Text] [Related]
11. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T
Prog Clin Biol Res; 1989; 317():971-84. PubMed ID: 2513588
[TBL] [Abstract][Full Text] [Related]
12. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
13. Effects of peptides derived from BACE1 catalytic domain on APP processing.
Yeon SW; Jeon YJ; Hwang EM; Kim TY
Peptides; 2007 Apr; 28(4):838-44. PubMed ID: 17293005
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls.
Tagliavini F; Ghiso J; Timmers WF; Giaccone G; Bugiani O; Frangione B
Lab Invest; 1990 Jun; 62(6):761-7. PubMed ID: 2113597
[TBL] [Abstract][Full Text] [Related]
15. Intracellular generation of amyloid beta-protein from amyloid beta-protein precursor fragment by direct cleavage with beta- and gamma-secretase.
Iizuka T; Shoji M; Kawarabayashi T; Sato M; Kobayashi T; Tada N; Kasai K; Matsubara E; Watanabe M; Tomidokoro Y; Hirai S
Biochem Biophys Res Commun; 1996 Jan; 218(1):238-42. PubMed ID: 8573139
[TBL] [Abstract][Full Text] [Related]
16. Amyloid precursor protein mRNA levels in Alzheimer's disease brain.
Preece P; Virley DJ; Costandi M; Coombes R; Moss SJ; Mudge AW; Jazin E; Cairns NJ
Brain Res Mol Brain Res; 2004 Mar; 122(1):1-9. PubMed ID: 14992810
[TBL] [Abstract][Full Text] [Related]
17. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
Multhaup G; Mechler H; Masters CL
J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
[TBL] [Abstract][Full Text] [Related]
19. Molecular neuropathology of Alzheimer's disease.
Masters CL; Beyreuther K
Arzneimittelforschung; 1995 Mar; 45(3A):410-2. PubMed ID: 7763335
[TBL] [Abstract][Full Text] [Related]
20. Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.
Baranowska-Bik A; Bik W; Wolinska-Witort E; Martynska L; Chmielowska M; Barcikowska M; Baranowska B
Neuro Endocrinol Lett; 2008 Feb; 29(1):75-9. PubMed ID: 18283248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
